| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3441124 | American Journal of Obstetrics and Gynecology | 2008 | 9 Pages |
Abstract
The complement activation product Bb in early pregnancy is a biomarker for elevated risk of preeclampsia. This observation suggests that events linked to activation of complement in early pregnancy are associated with the pathogenesis of preeclampsia.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Anne M. MB, BCh, BAO, MSPH, James R. PhD, Tim MD, MPH, Ronald S. MD, Margaret C. PhD, Patricia C. PhD, Jane E. MD, V. Michael MD,